Work

KRAS codon 12 and 13 mutations may guide the selection of irinotecan or oxaliplatin in first-line treatment of metastatic colorectal cancer

Year: 2019

Type: article

Study design: Observational Study

Source: Expert Review of Molecular Diagnostics

DOI: 10.1080/14737159.2019.1693266

Authors: Yakup Ergun, Yusuf Acikgoz, Oznur Bal, Gokhan Ucar, Merve Dirikoc, Eda Caliskan Yildirim, Nadiye Akdeniz, Dogan Uncu

Institution: Dicle University

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2989736148

FWCI: 0.56

Cites: 38

Cited by: 9

Related to: 10